Anzeige
Mehr »
Freitag, 13.06.2025 - Börsentäglich über 12.000 News
Anleger aufgepasst: Weltbank setzt jetzt ein neues Signal für Investoren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
275 Leser
Artikel bewerten:
(1)

Patients trust their doctors more when wearing ClearMask transparent masks compared to standard masks

First-of-its-kind study published in the Journal of American Medical Association Surgery says improved patient-provider communication through the ClearMask could lead to better patient outcomes, potential to reduce litigation

BALTIMORE, March 16, 2021 /PRNewswire/ -- A first-of-its-kind study published in the Journal of American Medical Association Surgery on March 11, 2021 suggests that doctors who wear ClearMask transparent face masks greatly improve communication with patients compared to doctors whose faces are blocked by a standard face mask. Results showed that providers who wore the ClearMask are not only better communicators, they are also perceived as having more empathy and elicit greater trust.

A standard face mask vs. a ClearMask transparent mask. You be the judge: which healthcare provider would you trust more?

"The study's overwhelmingly positive results on improved communication with the ClearMask validated what we knew all along: being able to see each other's faces is fundamentally human and an integral part of how we connect," said Allysa Dittmar, President of ClearMask, LLC. "The study's use of the ClearMask brand and its acceptance into a rigorous journal like the Journal of American Medical Association is a powerful testament to the importance of the ClearMask."

Use of standard masks may come at a cost, blocking critical facial expressions and non-verbal cues that affect communication, the patient-provider relationship, and risk for litigation.

Drs. Kratzke, Rosenbaum, Cox, et al. conducted a randomized clinical trial of 200 patients, in which surgeons were randomly selected to wear either a ClearMask transparent mask or a standard mask during a new patient visit. After the visit, the patients took a survey to evaluate the mask itself and the surgeon's communication, empathy, and trust, while answering validated questions from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS).

Compared to standard masks, patients reported improved communication with the ClearMask transparent masks, rating their physician significantly higher in providing understandable explanations, demonstrating empathy, and building trust. 100% of the patients whose provider wore the ClearMask preferred the transparent masks, citing improved provider communication and appreciation for full face visibility.

Healthcare entities routinely administer patient satisfaction questions like CG-CAHPS, and higher patient satisfaction scores may factor into greater reimbursement from the United States Centers for Medicare and Medicaid Services (CMS). Increased patient satisfaction can also lead to better patient health outcomes, improved quality of life, and decreased litigation against healthcare entities.

"Trust is the cornerstone of surgical care. Without it, patients would not let us operate on them or trust our judgment to forgo surgery. And how we speak may be more important than what we say," wrote Dr. Margaret Schwarze and Dr. Elle Kalbfellin an invited commentary to the study. "As surgeons, we do many bold things because they improve patient care, and wearing a clear mask with new patients should be one of them."

About ClearMask
The ClearMask brand is the first and only fully transparent mask on the market in the United States to have FDA 510(k) clearance as a Class II medical device. The mask is optimized for maximum clarity and comfort, and meets applicable ASTM Level 3 requirements for fluid resistance and flammability, which offers a high level of protection for medical use in environments such as operating rooms.

ClearMask, LLC started developing the transparent mask in 2017 after their deaf co-founder had an adverse surgery experience where masks blocked providers' faces, preventing effective communication and safety. The company has sold nearly 16 million masks to date for use in hospitals, clinics, schools, businesses, theaters, and other settings.

The masks can be purchased through the company's website at buy.theclearmask.com, starting at a box of 24 masks. The company has also partnered with several distributors, including Cardinal Health, Henry Schein, McKesson Medical-Surgical, Oaktree Products, and Owens & Minor.

Media Contact:
Margaret Justus
E-mail: press@theclearmask.com
Phone: 281-250-8253

Download Logo
Download Photo

Photo - https://mma.prnewswire.com/media/1456586/ClearMask_comparison.jpg

© 2021 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.